NCT04366258View on ClinicalTrials.gov

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

June 24, 2022

Conditions
Major Depressive Disorder
Interventions
DEVICE

Transcranial Photobiomodulator

Delivers laser-generated Near-Infrared Radiation (NIR) to forehead at 3 doses of irradiance - High (770 mW/cm2), Middle (300 mW/cm2), and Low (50 mW/cm2).

DEVICE

Sham

Transcranial Photobiomodulator delivers sham irradiance dose of 0 mW/cm2.

Trial Locations (3)

10016

New York University, New York

10962

Nathan Kline Institute, Orangeburg

02129

Massachusetts General Hospital, Charlestown

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

NYU Langone Health

OTHER

NCT04366258 - Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression | Biotech Hunter | Biotech Hunter